Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
UCL Technology Fund announces first close of £100m Fund 2
Quadruplex-binding compounds – a novel anticancer strategy
We have a first-in-class optimized small-molecule drug candidate ready for IND enabling studies with superior efficacy and activity against pancreatic cancer compared to existing agents, together with a distinct mechanism of action.
An introduction to UCLB’s new Associate Director of BioPharm
We recently interviewed Associate Director of BioPharm, Dr Mark Fisher, about his new position, the ever-developing field of technology transfer, and the importance of commercialisation in society today.
Latest news and highlights
Commercialising technology since 1993
As of July 2019